The Supreme Court will hear arguments Tuesday in a case challenging a series of actions the FDA took in 2016 and 2021 that made the abortion pill mifepristone easier to obtain.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec.